Historical Volume

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE1079.558.25 (+0.77 %)
PREV CLOSE ( ) 1071.30
OPEN PRICE ( ) 1073.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 33383
TODAY'S LOW / HIGH ( )1071.00 1095.95
52 WK LOW / HIGH ( )516.65 1095.95
NSE1080.309.35 (+0.87 %)
PREV CLOSE( ) 1070.95
OPEN PRICE ( ) 1071.00
BID PRICE (QTY) 1080.30 (2787)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1101089
TODAY'S LOW / HIGH( ) 1070.95 1096.00
52 WK LOW / HIGH ( )516.25 1096
Exchange
Period From  
Period To  
Date Open Price () High Price () Low Price () Close Price () Volume (000's) Turnover ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.